Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone for delirium superimposed on dementia
IRCT20250728066664N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Edaravone with Placebo (2 arms). Primary endpoint: Assessment of delirious state at day 30. Started Aug 2025; status: completed.
02
Drugs
edaravone
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20250728066664N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250728066664N1.